Gilead Sciences, Inc. GILD

+11.39%
Discovered (Elapsed 61days) Discovery price $150.89 Current price $168.08 Price updated

✅ Key Summary

Gilead Sciences, Inc. focuses on innovative therapeutics in areas such as HIV, liver diseases, and oncology. The company reported robust earnings recently, driven by strong sales of its key products. With a significant market capitalization, GILD remains a prominent player in the biotech industry.

Advertisement

🏢 Company Overview

Gilead Sciences, Inc. specializes in the research and development of antiviral drugs and therapies, particularly for HIV and hepatitis. In its latest earnings report, Gilead exceeded analysts' expectations, showcasing growth in its product pipeline and solid sales figures. The company has made strategic investments in oncology, which are expected to contribute to future revenue growth. Despite facing competition, Gild's extensive portfolio and strong market position lend it resilience. The stock has experienced fluctuations but remains attractive at its current valuation. With a market capitalization of over $187 billion, GILD is positioned for long-term stability. The calculated basis point indicates there is potential for value appreciation. Overall, Gilead's fundamentals suggest it is well-prepared for upcoming market challenges.

📰 Related News

  • Gilead's new drug shows promise in clinical trials
    Positive impact on stock as investors anticipate increased revenue.
  • Analysts raise GILD price target following strong earnings report
    Positive sentiment as market confidence grows.
  • Regulatory approval for key drug expected soon
    Potential for stock price increase if approval is granted.

🏭 Competitor Comparison

  • AbbVie Inc. ABBV
    AbbVie focuses on immunology and oncology, presenting a diversified portfolio compared to GILD.
  • Amgen Inc. AMGN
    Amgen has a strong presence in biotechnology but differs in product focus from GILD's antiviral treatments.
  • Bristol-Myers Squibb Company BMY
    BMY's emphasis on oncology contrasts with Gilead's stronghold in infectious diseases.

📅 Gilead Sciences, Inc. discovery history

This stock has been discovered 6 times.

DiscoveredDiscovery priceCurrent priceReturn
Aug 12, 2026 $135.87 $170.87 +25.76%
May 6, 2026 $136.30 $135.25 -0.77%
Apr 1, 2026 $140.30 $126.34 -9.95%
Jan 30, 2026 $141.95 $130.84 -7.83%
Dec 24, 2025 $125.67 $138.11 +9.90%
Go to the Gilead Sciences, Inc. ticker page →
Advertisement

Other recent discoveries

← Back to list